Un approccio multidisciplinare integrato bio-psico-sociale nella programmazione dell\u2019attivit\ue0 riabilitativa nelle Residenze Sanitarie Assistenziali (RSA)

Objectives, social role and organization of Italian nursing homes (RSA) are characterized by a pronounced regional differentiation that causes situations which are difficult to compare about expected outcomes. The definition of a functional outcome is particularly difficult in institutionalized patients and this is due to the failure of a conclusive moment of the rehabilitative treatment. Furthermore we often take care of patients who have already been admitted to intensive and/or extensive rehabilitation units time after time, without further functional profit margin. The inconstant presence of professional figures of rehabilitation in nursing homes\u2019 staff makes difficult the drafting of an adequate rehabilitative project, especially for the multiple needs of frail old people. Starting with these assumptions, authors hypothesize and adopt a model of sanitary organization to consent a correct allocation of available resources, according to the patient\u2019s needs. They stratified all nursing home patients, using the Multidimensional Prognostic Index (MPI) and \u201cScheda di osservazione intermedia assistenza\u201d (SOSIA), and measured the residual function. They concluded that a multidimensional evaluation of patients allows to identify wellness (of the sick person and of caregivers) as the main objective; nursing home organization could be think as a \u201ccomplex supportive prosthesis for old people\u201d, made by the interaction among structure, operators and activities. In Italia gli obiettivi, il ruolo sociale e l\u2019organizzazione delle Residenze Sanitarie Assistenziali (RSA) sono caratterizzati da una marcata differenziazione regionale che crea situazioni di difficile confronto sugli outcome attesi. In particolare nel paziente istituzionalizzato \ue8 molto difficoltosa soprattutto la definizione di un outcome funzionale, mancando un momento conclusivo del trattamento riabilitativo e trovandoci spesso di fronte a pazienti che hanno gi\ue0 avuto pi\uf9 ricoveri in regime di riabilitazione intensiva e/o estensiva e quindi senza pi\uf9 ulteriori margini di guadagno funzionale. L\u2019incostante presenza di figure professionali della riabilitazione nell\u2019organico delle RSA, rende difficoltosa la redazione di un Progetto riabilitativo adeguato alle molteplici esigenze dell\u2019anziano fragile. Gli autori partendo da questi presupposti ipotizzano ed applicano un modello di organizzazione sanitaria per consentire una corretta allocazione delle risorse disponibili, coerentemente con i bisogni dell\u2019ospite. Dopo aver stratificato tutti i pazienti residenti in RSA con il Multidimensional Prognostic Index (MPI) e (Scheda di osservazione intermedia assistenza) SOSIA e misurato la funzione residua concludono che la valutazione multidimensionale dell\u2019ospite consente di identificare nel benessere (del malato e dei caregivers) l\u2019obiettivo principale da conseguire, ripensando l\u2019organizzazione della RSA come una \u201cprotesi complessa di sostegno all\u2019anziano\u201d, composta dall\u2019interazione tra struttura, operatori e attivit\ue

Pharmacogenetic Tests in Reducing Accesses to Emergency Services and Days of Hospitalization in Bipolar Disorder: A 2-Year Mirror Analysis

Despite the enormous costs associated to mood disorders\u2019, few studies evaluate potential cost saving from the use of pharmacogenetic tests (PGT). This study compares 12 months before the execution of the PGT versus 12 months after, in terms of number and days of hospitalization and accesses to emergency services, in a sample of 30 patients affected by bipolar disorder. Secondarily, the study gives an economic value to the data based on the diagnosis-related group (DRG). Patients included in the study were required to be aged 6518 years, sign an informed consent, have a score of Clinical Global Impression item Severity (CGIs) 653, and have a discordant therapy compared to the PGT in the 12 months preceding it and a therapy consistent with it for the following 12 months. Cost saving has been evaluated by paired t-tests in a mirror analysis. Statistically significant differences in all the comparisons (p < 0.0001) emerged. Important cost saving emerged after the use of PGT (\u20ac148,920 the first year versus \u20ac39,048 the following year). Despite the small sample size and lack of a control group in this study, the potential role of PGT in cost saving for the treatment of bipolar disorder treatment emerged. To confirm this result, larger and clinical trials are needed

Four clinical cases of recurrent surgery addiction (polyop\ue9r\ue9s): diagnostic classification in the DSM-IV-TR vs DSM-5

The article presents four clinical cases of patients with the common history of recurrent surgery. These conditions are interesting first of all for general medicine and surgery, apart from psychiatry. Indeed, patients with these characteristics are almost invariably subjected to psychiatric evaluation by internal doctors and surgeons and this is evident in our case reports, despite the rarity of the phenomenon in latest decades aside from plastic surgery. The first aim of the study is to compare diagnostic classifications between DSM-IV-TR and DSM-5 in reference to the case reports of recurrent surgery in order to observe the changes occurring in the diagnostic criteria and classification and the different attitude of the two manuals towards these disorders. The second endpoint is to describe the common features and the differences between the cases that could motivate a different prognostic evolution to raise a hypothesis that could be a starting point for further research. According to previous classification of mental disorders in the DSM IV-TR, patients addicted to recurrent surgery are included in the diagnostic category of \u201cFactitious Disorder with Predominantly Physical Signs and Symptoms\u201d. In the DSM-5 typical clinical manifestations of recurrent surgery are excluded from diagnostic criterions of \u201cFactitious Disorder\u201d. The new manual moves away from the classic nosography tradition and highlights a bigger importance of an objective clinical observation of patients in comparison with the sole clinical history: the most suitable diagnosis is the \u201cSomatic Symptom Disorder\u201d

Medically unexplained physical symptoms in hospitalized patients: A 9-year retrospective observational study

Introduction: \u201cMedically Unexplained Physical Symptoms\u201d (MUPS) defines a subgroup of patients presenting physical symptoms of unclear origin. The study aims to profile clinical and socio-demographic characteristics of patients with MUPS. Materials and Methods: This 9-years observational retrospective study assesses all patients admitted between 2008 and 2016 in the divisions of neurology and gastroenterology. Socio-demographic and clinical variables were evaluated: gender, age, diagnosis or diagnostic hypothesis, presence of psychiatric comorbidities, psychiatric evaluation, pharmacological treatment, number of admissions/visits. Results: Among 2,479 neurological patients 10.1% presented MUPS. Patients were more frequently women (63.5%), with a mean age of about 50 years. Reported symptoms were headache (22.6%), seizures (8.7%), vertigo (5.9%), fibromyalgia (5.5%), paresthesia (5.1%), visual disturbances (5.1%), amnesia (3.9%). The diagnosis was somatoform disorder in 6.3% of cases, conversion disorder in 2.7%, and somatic symptom disorder in 1.5% only. 2,560 outpatients were evaluated in gastroenterology division. 9.6% (n = 248) of patients had MUPS; 62.1% of them were women. The most affected age group ranged between 15 and 45 years. The most frequent diagnoses were functional abdominal pain (50%), dysmotility-like dyspepsia (26.6%), irritable bowel syndrome (10.4%), meteorism of unknown cause (2.4%), hiccup (1.6%), burning mouth syndrome (1.2%). No patients received a diagnosis of somatic symptom disorder. Discussion: Patients with MUPS are more often women, of middle age, with self-referred specific symptomatology. While neurological patients received a diagnostic-therapeutic approach in line with the literature, gastroenterological patients mainly received antipsychotics. A more comprehensive assessment and a development of psychoeducational interventions are needed to improve patients' quality and quantity of life

Paroxetine versus vortioxetine for depressive symptoms in postmenopausal transition: A preliminary study

Background: The impact of menopause is a consequence of social, physical and mental changes; hormonal changes play an important role in inducing an increased risk of developing depressive symptoms. It is essential to treat mood and vasomotor symptoms and to prevent their onset to promote an improvement in the quality of life, both in terms of clinical and psychological conditions. Objective: This observational study aims to compare paroxetine and vortioxetine in a sample of patients affected by postmenopausal depression attending the Anxiety and Depression Clinic in terms of: efficacy in determining clinical remission (HDRS 64 7) and tolerability; improvement of autonomic and cognitive symptoms. Methods: 39 female outpatients with a diagnosis of Postmenopausal Depression (according to DSM-5 criteria) were evaluated as the routine clinical practice through the following scales: Hamilton Depression Rating Scale (HDRS); Menopause Rating Scale (MRS); Montreal Cognitive Assessment (MoCA); Antidepressant Side-Effect Checklist (ASEC); data from/of baseline, after 8 weeks and 12 weeks were recorded. Results: Both antidepressants resulted to be effective in clinical remission (HDRS 64 7) without statistical differences between the two groups (p = 0.3), although paroxetine showed a faster remission than vortioxetine (p = 0.01). Autonomic symptoms showed a higher improvement in the vortioxetine group (p = 0.002). Paroxetine group referred insomnia and sexual problems while patients taking vortioxetine referred diarrhoea and palpitations. Data show a superiority of cognitive performance in the Paroxetine group (p = 0.005), contrary to what stated in literature. Conclusions: Data are related to a small sample retrospectively assessed trough a 6-month observation period. Thus, the preliminary results need further research to be confirmed

Resilience in older adults: influence of the admission in nursing home and psychopathology

Objective: The resilience is the ability to face and overcome the adversities of life. The first aim of the study is to explore this construct referring to ageing. The characteristics of resilience were assessed in older adults, the additional endpoint is to focus on the role of institutionalization in nursing home and on the influence of chronic psychiatric illness. Method: 197 patients (aged 65 and over) have been enrolled in the observational cross-sectional study. The sample was composed by 91 subjects who lived at home (Community-dwelling, group I), 56 subjects who lived in a nursing home (Nursing-home, group II) and 50 subjects who lived in a nursing home, suffering from psychiatric disorders (Psychogeriatric division, group III). The resilience was evaluated through the Resilience Scale (RS) and the Connor-Davidson Resilience Scale (CD-RISC). Results: The mean total score of RS decreased from the group I to the group III (55.4, 49.8 and 46.6, respectively). Moreover, using pairwise comparison among groups, significant differences between the group I and the group II (5.6, p<0.0001) and between the group I and the group III (8.8, p<0.0001) were found. In the CD-RISC total score, significant differences among the three groups (p<0.0001) were observed, with a decrease of the mean values from the group I to the group III (66.2, 62.4 and 56.4, respectively). The pairwise comparison showed significant differences between the group III and the group I (p<0.0001) and between the group III and the group II (p=0.03). Conclusion: The first aim of the study to explore the construct of resilience in reference to ageing both as a dispositional resource and as an environment adjusted strategy of adaptation has been reached: the characteristics of resilience were assessed in older adults. Moreover, the second endpoint has been achieved too as the data showed that resilience skills of older adults are compromised both by institutionalization and by concurrent diagnosis of psychiatric disorder

Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trialResearch in context

Summary: Background: Major depressive disorder (MDD) is prevalent and disabling among older adults. Standing on its tolerability profile, vortioxetine might be a promising alternative to selective serotonin reuptake inhibitors (SSRIs) in such a vulnerable population. Methods: We conducted a randomised, assessor- and statistician-blinded, superiority trial including older adults with MDD. The study was conducted between 02/02/2019 and 02/22/2023 in 11 Italian Psychiatric Services. Participants were randomised to vortioxetine or one of the SSRIs, selected according to common practice. Treatment discontinuation due to adverse events after six months was the primary outcome, for which we aimed to detect a 12% difference in favour of vortioxetine. The study was registered in the online repository clinicaltrials.gov (NCT03779789). Findings: The intention-to-treat population included 179 individuals randomised to vortioxetine and 178 to SSRIs. Mean age was 73.7 years (standard deviation 6.1), and 264 participants (69%) were female. Of those on vortioxetine, 78 (44%) discontinued the treatment due to adverse events at six months, compared to 59 (33%) of those on SSRIs (odds ratio 1.56; 95% confidence interval 1.01–2.39). Adjusted and per-protocol analyses confirmed point estimates in favour of SSRIs, but without a significant difference. With the exception of the unadjusted survival analysis showing SSRIs to outperform vortioxetine, secondary outcomes provided results consistent with a lack of substantial safety and tolerability differences between the two arms. Overall, no significant differences emerged in terms of response rates, depressive symptoms and quality of life, while SSRIs outperformed vortioxetine in terms of cognitive performance. Interpretation: As opposed to what was previously hypothesised, vortioxetine did not show a better tolerability profile compared to SSRIs in older adults with MDD in this study. Additionally, hypothetical advantages of vortioxetine on depression-related cognitive symptoms might be questioned. The study's statistical power and highly pragmatic design allow for generalisability to real-world practice. Funding: The study was funded by the Italian Medicines Agency within the “2016 Call for Independent Drug Research”